939.6000 4.90 (0.52%)
NSE Jun 23, 2025 15:31 PM
Volume: 136.0K
 

939.60
0.52%
BOB Capital Markets Ltd.
Revenue/EBITDA/ PAT grew 6.7%/8% and 19% above our estimates. EBITDA margin reported 20bps above estimates of 15.4% in 4QFY25
Alembic Pharmaceuticals Ltd. is trading below its 30 day SMA of 970.0
More from Alembic Pharmaceuticals Ltd.
Recommended